nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—ALB—multiple sclerosis	0.538	1	CbGaD
Acepromazine—SLC22A1—Cladribine—multiple sclerosis	0.182	0.652	CbGbCtD
Acepromazine—ALB—Prednisone—multiple sclerosis	0.0647	0.232	CbGbCtD
Acepromazine—ALB—Methotrexate—multiple sclerosis	0.0324	0.116	CbGbCtD
Acepromazine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0305	0.261	CbGeAlD
Acepromazine—HTR2A—trigeminal nerve—multiple sclerosis	0.00802	0.0687	CbGeAlD
Acepromazine—DRD1—nerve—multiple sclerosis	0.00751	0.0643	CbGeAlD
Acepromazine—HTR2A—pons—multiple sclerosis	0.00564	0.0483	CbGeAlD
Acepromazine—DRD2—nerve—multiple sclerosis	0.00444	0.038	CbGeAlD
Acepromazine—HTR2A—pineal body—multiple sclerosis	0.00403	0.0345	CbGeAlD
Acepromazine—HTR2A—peripheral nervous system—multiple sclerosis	0.00376	0.0322	CbGeAlD
Acepromazine—DRD1—brainstem—multiple sclerosis	0.00323	0.0276	CbGeAlD
Acepromazine—HTR2A—nerve—multiple sclerosis	0.00293	0.0251	CbGeAlD
Acepromazine—HTR1A—brainstem—multiple sclerosis	0.00211	0.0181	CbGeAlD
Acepromazine—DRD1—midbrain—multiple sclerosis	0.00206	0.0176	CbGeAlD
Acepromazine—ADRA1A—brainstem—multiple sclerosis	0.00194	0.0166	CbGeAlD
Acepromazine—DRD2—brainstem—multiple sclerosis	0.00191	0.0163	CbGeAlD
Acepromazine—DRD2—retina—multiple sclerosis	0.00184	0.0157	CbGeAlD
Acepromazine—ADRA1B—nervous system—multiple sclerosis	0.00181	0.0155	CbGeAlD
Acepromazine—ADRA1B—central nervous system—multiple sclerosis	0.00175	0.0149	CbGeAlD
Acepromazine—DRD1—nervous system—multiple sclerosis	0.00169	0.0145	CbGeAlD
Acepromazine—DRD1—central nervous system—multiple sclerosis	0.00163	0.0139	CbGeAlD
Acepromazine—ADRA1B—brain—multiple sclerosis	0.00139	0.0119	CbGeAlD
Acepromazine—HTR1A—midbrain—multiple sclerosis	0.00134	0.0115	CbGeAlD
Acepromazine—SLC22A1—nervous system—multiple sclerosis	0.00134	0.0115	CbGeAlD
Acepromazine—HTR1A—spinal cord—multiple sclerosis	0.00131	0.0112	CbGeAlD
Acepromazine—DRD1—brain—multiple sclerosis	0.00129	0.0111	CbGeAlD
Acepromazine—SLC22A1—central nervous system—multiple sclerosis	0.00129	0.011	CbGeAlD
Acepromazine—HTR2A—brainstem—multiple sclerosis	0.00126	0.0108	CbGeAlD
Acepromazine—DRD2—midbrain—multiple sclerosis	0.00121	0.0104	CbGeAlD
Acepromazine—HTR2A—retina—multiple sclerosis	0.00121	0.0104	CbGeAlD
Acepromazine—HTR1A—nervous system—multiple sclerosis	0.0011	0.00946	CbGeAlD
Acepromazine—HTR1A—central nervous system—multiple sclerosis	0.00106	0.00911	CbGeAlD
Acepromazine—HTR1A—cerebellum—multiple sclerosis	0.00104	0.0089	CbGeAlD
Acepromazine—SLC22A1—brain—multiple sclerosis	0.00102	0.00876	CbGeAlD
Acepromazine—ADRA1A—nervous system—multiple sclerosis	0.00102	0.00872	CbGeAlD
Acepromazine—DRD2—nervous system—multiple sclerosis	0.000998	0.00855	CbGeAlD
Acepromazine—ADRA1A—central nervous system—multiple sclerosis	0.000981	0.0084	CbGeAlD
Acepromazine—ALB—brain—multiple sclerosis	0.000979	0.00838	CbGeAlD
Acepromazine—DRD2—central nervous system—multiple sclerosis	0.000961	0.00823	CbGeAlD
Acepromazine—ADRA1A—cerebellum—multiple sclerosis	0.000958	0.00821	CbGeAlD
Acepromazine—DRD2—cerebellum—multiple sclerosis	0.000939	0.00804	CbGeAlD
Acepromazine—HTR2A—medulla oblongata—multiple sclerosis	0.000876	0.0075	CbGeAlD
Acepromazine—HTR1A—brain—multiple sclerosis	0.000845	0.00723	CbGeAlD
Acepromazine—HTR2A—midbrain—multiple sclerosis	0.000801	0.00686	CbGeAlD
Acepromazine—HTR2A—spinal cord—multiple sclerosis	0.000781	0.00669	CbGeAlD
Acepromazine—ADRA1A—brain—multiple sclerosis	0.000779	0.00667	CbGeAlD
Acepromazine—DRD2—brain—multiple sclerosis	0.000763	0.00653	CbGeAlD
Acepromazine—HTR2A—nervous system—multiple sclerosis	0.000658	0.00564	CbGeAlD
Acepromazine—HTR2A—central nervous system—multiple sclerosis	0.000634	0.00543	CbGeAlD
Acepromazine—HTR2A—cerebellum—multiple sclerosis	0.00062	0.00531	CbGeAlD
Acepromazine—Ethopropazine—BCHE—multiple sclerosis	0.000597	0.284	CrCbGaD
Acepromazine—HTR2A—brain—multiple sclerosis	0.000503	0.00431	CbGeAlD
Acepromazine—Triflupromazine—BCHE—multiple sclerosis	0.000489	0.233	CrCbGaD
Acepromazine—Chlorpromazine—BCHE—multiple sclerosis	0.000236	0.112	CrCbGaD
Acepromazine—Thioproperazine—ALB—multiple sclerosis	0.000182	0.0865	CrCbGaD
Acepromazine—Thiothixene—ALB—multiple sclerosis	0.000179	0.0851	CrCbGaD
Acepromazine—Pipotiazine—ALB—multiple sclerosis	0.000179	0.0851	CrCbGaD
Acepromazine—Clomipramine—ALB—multiple sclerosis	0.000141	0.0673	CrCbGaD
Acepromazine—Chlorpromazine—ALB—multiple sclerosis	9.68e-05	0.0461	CrCbGaD
Acepromazine—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	3.32e-05	0.000523	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—IL2RA—multiple sclerosis	3.31e-05	0.000521	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PTGER4—multiple sclerosis	3.27e-05	0.000516	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CXCL10—multiple sclerosis	3.27e-05	0.000515	CbGpPWpGaD
Acepromazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.22e-05	0.000508	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PGR—multiple sclerosis	3.22e-05	0.000508	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CXCL10—multiple sclerosis	3.21e-05	0.000506	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CCL5—multiple sclerosis	3.2e-05	0.000505	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—CCR5—multiple sclerosis	3.18e-05	0.000501	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CXCR3—multiple sclerosis	3.16e-05	0.000498	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	3.15e-05	0.000496	CbGpPWpGaD
Acepromazine—DRD2—Circadian rythm related genes—IL6—multiple sclerosis	3.14e-05	0.000494	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CD28—multiple sclerosis	3.13e-05	0.000493	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—IL2RA—multiple sclerosis	3.13e-05	0.000493	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—CCL5—multiple sclerosis	3.1e-05	0.000488	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCR2—multiple sclerosis	3.07e-05	0.000485	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—IL2RA—multiple sclerosis	3.07e-05	0.000484	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CCL5—multiple sclerosis	3.05e-05	0.000481	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—CCL5—multiple sclerosis	3.05e-05	0.00048	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—CCR5—multiple sclerosis	3.02e-05	0.000477	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	2.98e-05	0.00047	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—IL2RA—multiple sclerosis	2.98e-05	0.00047	CbGpPWpGaD
Acepromazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.92e-05	0.000461	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCL3—multiple sclerosis	2.92e-05	0.000461	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—POMC—multiple sclerosis	2.89e-05	0.000455	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CCR5—multiple sclerosis	2.88e-05	0.000455	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.87e-05	0.000453	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.86e-05	0.000451	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—BCHE—multiple sclerosis	2.86e-05	0.00045	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—IL2RA—multiple sclerosis	2.84e-05	0.000448	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CNR1—multiple sclerosis	2.84e-05	0.000447	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PTGER4—multiple sclerosis	2.81e-05	0.000444	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CCL5—multiple sclerosis	2.81e-05	0.000443	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—CCR5—multiple sclerosis	2.79e-05	0.00044	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCL3—multiple sclerosis	2.78e-05	0.000439	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PGR—multiple sclerosis	2.77e-05	0.000437	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CCL5—multiple sclerosis	2.77e-05	0.000436	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.75e-05	0.000433	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CCR5—multiple sclerosis	2.75e-05	0.000433	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—CCR5—multiple sclerosis	2.74e-05	0.000432	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	2.73e-05	0.00043	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CXCR3—multiple sclerosis	2.72e-05	0.000428	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	2.71e-05	0.000427	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—IL2RA—multiple sclerosis	2.71e-05	0.000427	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—IL2RA—multiple sclerosis	2.7e-05	0.000426	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CD28—multiple sclerosis	2.69e-05	0.000424	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	2.69e-05	0.000423	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PTGER4—multiple sclerosis	2.68e-05	0.000422	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	2.67e-05	0.000421	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	2.65e-05	0.000417	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	2.64e-05	0.000417	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PGR—multiple sclerosis	2.64e-05	0.000416	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—POMC—multiple sclerosis	2.62e-05	0.000413	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	2.59e-05	0.000408	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.58e-05	0.000407	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCL3—multiple sclerosis	2.57e-05	0.000405	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—CCL2—multiple sclerosis	2.56e-05	0.000404	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	2.56e-05	0.000404	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CXCL10—multiple sclerosis	2.55e-05	0.000403	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CCR5—multiple sclerosis	2.53e-05	0.000399	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCL3—multiple sclerosis	2.53e-05	0.000398	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	2.52e-05	0.000397	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL2RA—multiple sclerosis	2.5e-05	0.000393	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	2.49e-05	0.000393	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	2.48e-05	0.000391	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	2.47e-05	0.00039	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PTGER4—multiple sclerosis	2.47e-05	0.000389	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	2.46e-05	0.000387	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	2.44e-05	0.000385	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	2.44e-05	0.000385	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PGR—multiple sclerosis	2.43e-05	0.000384	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	2.43e-05	0.000383	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	2.4e-05	0.000379	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PGR—multiple sclerosis	2.39e-05	0.000377	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	2.39e-05	0.000376	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	2.38e-05	0.000375	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CD28—multiple sclerosis	2.36e-05	0.000373	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	2.36e-05	0.000373	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	2.35e-05	0.00037	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	2.34e-05	0.00037	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—TYK2—multiple sclerosis	2.33e-05	0.000367	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CD28—multiple sclerosis	2.33e-05	0.000367	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	2.32e-05	0.000366	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCR2—multiple sclerosis	2.32e-05	0.000366	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	2.3e-05	0.000362	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	2.28e-05	0.00036	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	2.28e-05	0.000359	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	2.25e-05	0.000355	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	2.24e-05	0.000353	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CD86—multiple sclerosis	2.23e-05	0.000352	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.22e-05	0.00035	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	2.21e-05	0.000348	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCL5—multiple sclerosis	2.2e-05	0.000347	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	2.2e-05	0.000346	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	2.18e-05	0.000343	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	2.15e-05	0.000338	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	2.14e-05	0.000338	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CNR1—multiple sclerosis	2.14e-05	0.000338	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—IL2—multiple sclerosis	2.13e-05	0.000336	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	2.11e-05	0.000332	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	2.1e-05	0.000331	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	2.1e-05	0.000331	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	2.09e-05	0.00033	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	2.06e-05	0.000325	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—SPP1—multiple sclerosis	2.04e-05	0.000321	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	2e-05	0.000316	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCR5—multiple sclerosis	1.98e-05	0.000312	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—POMC—multiple sclerosis	1.98e-05	0.000312	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL2RA—multiple sclerosis	1.95e-05	0.000308	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	1.95e-05	0.000307	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—IL2—multiple sclerosis	1.94e-05	0.000305	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	1.94e-05	0.000305	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	1.93e-05	0.000304	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CD86—multiple sclerosis	1.92e-05	0.000303	CbGpPWpGaD
Acepromazine—ALB—Metabolism—BCHE—multiple sclerosis	1.91e-05	0.000301	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	1.91e-05	0.000301	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	1.91e-05	0.000301	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	1.91e-05	0.0003	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	1.9e-05	0.000299	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	1.89e-05	0.000298	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	1.87e-05	0.000294	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	1.86e-05	0.000293	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	1.84e-05	0.000289	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	1.83e-05	0.000288	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—APOE—multiple sclerosis	1.8e-05	0.000284	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—IL2—multiple sclerosis	1.8e-05	0.000284	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	1.8e-05	0.000284	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	1.76e-05	0.000277	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	1.75e-05	0.000276	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	1.75e-05	0.000275	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	1.73e-05	0.000273	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—APOE—multiple sclerosis	1.72e-05	0.000271	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	1.7e-05	0.000269	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	1.69e-05	0.000267	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CD86—multiple sclerosis	1.69e-05	0.000266	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	1.68e-05	0.000265	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	1.67e-05	0.000263	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	1.67e-05	0.000263	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCL5—multiple sclerosis	1.66e-05	0.000262	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CD86—multiple sclerosis	1.66e-05	0.000262	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	1.63e-05	0.000258	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CD80—multiple sclerosis	1.63e-05	0.000257	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	1.63e-05	0.000256	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	1.62e-05	0.000256	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	1.61e-05	0.000254	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	1.6e-05	0.000252	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	1.6e-05	0.000252	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	1.59e-05	0.00025	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	1.59e-05	0.00025	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.55e-05	0.000245	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—APOE—multiple sclerosis	1.55e-05	0.000244	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—POMC—multiple sclerosis	1.55e-05	0.000244	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	1.54e-05	0.000242	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCL2—multiple sclerosis	1.52e-05	0.000239	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	1.51e-05	0.000238	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	1.5e-05	0.000236	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—MAPK1—multiple sclerosis	1.48e-05	0.000234	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.48e-05	0.000234	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—POMC—multiple sclerosis	1.48e-05	0.000233	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	1.48e-05	0.000233	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	1.47e-05	0.000232	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	1.47e-05	0.000232	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	1.46e-05	0.000231	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	1.45e-05	0.000229	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.44e-05	0.000227	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	1.44e-05	0.000227	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.42e-05	0.000224	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.41e-05	0.000222	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—TGFB1—multiple sclerosis	1.4e-05	0.000221	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CD80—multiple sclerosis	1.4e-05	0.000221	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—MAPK1—multiple sclerosis	1.38e-05	0.000217	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TYK2—multiple sclerosis	1.38e-05	0.000217	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.36e-05	0.000214	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—ALB—multiple sclerosis	1.35e-05	0.000212	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.34e-05	0.000211	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	1.33e-05	0.00021	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—POMC—multiple sclerosis	1.33e-05	0.00021	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.31e-05	0.000207	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	1.3e-05	0.000205	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.27e-05	0.000201	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	1.27e-05	0.0002	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	1.24e-05	0.000196	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.23e-05	0.000194	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	1.21e-05	0.000191	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.21e-05	0.000191	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.19e-05	0.000187	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	1.18e-05	0.000186	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.17e-05	0.000184	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.15e-05	0.000181	CbGpPWpGaD
Acepromazine—ALB—Metabolism—APOE—multiple sclerosis	1.15e-05	0.000181	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL2—multiple sclerosis	1.14e-05	0.00018	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.14e-05	0.00018	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—IL6—multiple sclerosis	1.14e-05	0.00018	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	1.13e-05	0.000178	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	1.13e-05	0.000178	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.13e-05	0.000177	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.12e-05	0.000176	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	1.1e-05	0.000174	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.1e-05	0.000174	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MMP9—multiple sclerosis	1.08e-05	0.000171	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.08e-05	0.00017	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.04e-05	0.000164	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	1.02e-05	0.000161	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	1e-05	0.000158	CbGpPWpGaD
Acepromazine—ALB—Metabolism—POMC—multiple sclerosis	9.88e-06	0.000156	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	9.84e-06	0.000155	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	9.79e-06	0.000154	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—STAT3—multiple sclerosis	9.63e-06	0.000152	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	9.37e-06	0.000148	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	9.33e-06	0.000147	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	9.32e-06	0.000147	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MYC—multiple sclerosis	8.95e-06	0.000141	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	8.93e-06	0.000141	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	8.87e-06	0.00014	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	8.76e-06	0.000138	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL2—multiple sclerosis	8.64e-06	0.000136	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	8.6e-06	0.000136	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	8.5e-06	0.000134	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	8.46e-06	0.000133	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	8.33e-06	0.000131	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	8.29e-06	0.000131	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	8.28e-06	0.000131	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	8.18e-06	0.000129	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	8.05e-06	0.000127	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	7.89e-06	0.000124	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	7.88e-06	0.000124	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	7.7e-06	0.000121	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	7.68e-06	0.000121	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	7.53e-06	0.000119	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	7.33e-06	0.000116	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	7.31e-06	0.000115	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	7.27e-06	0.000115	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	7.17e-06	0.000113	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	7.16e-06	0.000113	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	7.01e-06	0.00011	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MYC—multiple sclerosis	6.76e-06	0.000107	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	6.74e-06	0.000106	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL6—multiple sclerosis	6.73e-06	0.000106	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	6.65e-06	0.000105	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	6.63e-06	0.000105	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	6.61e-06	0.000104	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	6.51e-06	0.000103	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	6.51e-06	0.000103	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	6.5e-06	0.000102	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	6.37e-06	0.0001	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	5.79e-06	9.12e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	5.51e-06	8.68e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL6—multiple sclerosis	5.08e-06	8.01e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	5e-06	7.88e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	4.89e-06	7.71e-05	CbGpPWpGaD
